25 XP   0   0   10

Biora Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Biora Therapeutics Inc together

PenkeI guess you are interested in Biora Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biora Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biora Therapeutics Inc

I send you an email if I find something interesting about Biora Therapeutics Inc.

Quick analysis of Biora Therapeutics Inc (30 sec.)










What can you expect buying and holding a share of Biora Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
4.8%

What is your share worth?

Current worth
$-2.84
Expected worth in 1 year
$-2.74
How sure are you?
23.8%

+ What do you gain per year?

Total Gains per Share
$0.10
Return On Investment
16.5%

For what price can you sell your share?

Current Price per Share
$0.61
Expected price per share
$0.585 - $0.7677
How sure are you?
50%

1. Valuation of Biora Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)

$0.61

Intrinsic Value Per Share

$28.61 - $35.48

Total Value Per Share

$25.77 - $32.64

2. Growth of Biora Therapeutics Inc (5 min.)




Is Biora Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?-$101.4m-$100.2m-$10.4m-9.4%

How much money is Biora Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$30.5m-$14m-$16.4m-53.8%
Net Profit Margin-222,587.5%-305,366.5%--

How much money comes from the company's main activities?

3. Financial Health of Biora Therapeutics Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#993 / 1010

Most Revenue
#718 / 1010

Most Profit
#801 / 1010

Most Efficient
#1003 / 1010

What can you expect buying and holding a share of Biora Therapeutics Inc? (5 min.)

Welcome investor! Biora Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Biora Therapeutics Inc.

What can you expect buying and holding a share of Biora Therapeutics Inc?

First you should know what it really means to hold a share of Biora Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Biora Therapeutics Inc is $0.607. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biora Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biora Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-2.84. Based on the TTM, the Book Value Change Per Share is $0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biora Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.43-71.0%-0.85-140.6%-0.32-52.4%-1.04-171.7%-1.02-168.7%
Usd Book Value Change Per Share0.000.0%0.034.1%-0.08-13.6%-0.14-23.4%-0.14-22.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.011.0%
Usd Total Gains Per Share0.000.0%0.034.1%-0.08-13.6%-0.14-23.4%-0.13-21.3%
Usd Price Per Share1.10-2.12-1.02-2.45-2.33-
Price to Earnings Ratio-0.64--0.90--0.87--0.70--0.66-
Price-to-Total Gains Ratio10.39--14.77--3.91--3.91-
Price to Book Ratio-0.39--0.66--0.36--1.69--1.61-
Price-to-Total Gains Ratio10.39--14.77--3.91--3.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.607
Number of shares1647
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.03-0.14
Usd Total Gains Per Share0.03-0.14
Gains per Quarter (1647 shares)41.18-233.51
Gains per Year (1647 shares)164.71-934.02
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101651550-934-944
203293200-1868-1878
304944850-2802-2812
406596500-3736-3746
508248150-4670-4680
609889800-5604-5614
70115311450-6538-6548
80131813100-7472-7482
90148214750-8406-8416
100164716400-9340-9350

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.021.00.00.0%0.021.00.00.0%
Book Value Change Per Share2.01.01.050.0%3.08.01.025.0%4.013.03.020.0%4.013.04.019.0%4.013.04.019.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.020.04.8%1.00.020.04.8%
Total Gains per Share2.01.01.050.0%3.08.01.025.0%4.013.03.020.0%5.013.03.023.8%5.013.03.023.8%

Fundamentals of Biora Therapeutics Inc

About Biora Therapeutics Inc

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-23 03:20:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Biora Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biora Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biora Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-222,587.5%+222,587.5%
TTM-222,587.5%YOY-305,366.5%+82,779.0%
TTM-222,587.5%5Y-108,771.6%-113,815.9%
5Y-108,771.6%10Y-103,594.4%-5,177.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--207.2%+207.2%
TTM-222,587.5%-216.8%-222,370.7%
YOY-305,366.5%-282.3%-305,084.2%
5Y-108,771.6%-436.8%-108,334.8%
10Y-103,594.4%-597.3%-102,997.1%
1.1.2. Return on Assets

Shows how efficient Biora Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • -49.4% Return on Assets means that Biora Therapeutics Inc generated $-0.49 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biora Therapeutics Inc:

  • The MRQ is -49.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -86.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-49.4%TTM-86.6%+37.2%
TTM-86.6%YOY-24.5%-62.1%
TTM-86.6%5Y-42.3%-44.3%
5Y-42.3%10Y-40.3%-2.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-49.4%-13.3%-36.1%
TTM-86.6%-12.8%-73.8%
YOY-24.5%-11.6%-12.9%
5Y-42.3%-13.8%-28.5%
10Y-40.3%-15.6%-24.7%
1.1.3. Return on Equity

Shows how efficient Biora Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • 0.0% Return on Equity means Biora Therapeutics Inc generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biora Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY--14.9%+14.9%
5Y--19.3%+19.3%
10Y--20.1%+20.1%

1.2. Operating Efficiency of Biora Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biora Therapeutics Inc is operating .

  • Measures how much profit Biora Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biora Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-186,737.5%+186,737.5%
TTM-186,737.5%YOY-226,655.6%+39,918.1%
TTM-186,737.5%5Y-84,556.9%-102,180.6%
5Y-84,556.9%10Y-80,532.6%-4,024.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--298.0%+298.0%
TTM-186,737.5%-238.5%-186,499.0%
YOY-226,655.6%-288.4%-226,367.2%
5Y-84,556.9%-486.2%-84,070.7%
10Y-80,532.6%-628.4%-79,904.2%
1.2.2. Operating Ratio

Measures how efficient Biora Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biora Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1,887.750-1,887.750
TTM1,887.750YOY2,289.924-402.174
TTM1,887.7505Y863.643+1,024.107
5Y863.64310Y822.587+41.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.235-3.235
TTM1,887.7503.310+1,884.440
YOY2,289.9243.838+2,286.086
5Y863.6435.679+857.964
10Y822.5877.823+814.764

1.3. Liquidity of Biora Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biora Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.30 means the company has $0.30 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biora Therapeutics Inc:

  • The MRQ is 0.303. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.446. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.303TTM0.446-0.143
TTM0.446YOY1.573-1.127
TTM0.4465Y1.057-0.611
5Y1.05710Y1.007+0.050
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3033.863-3.560
TTM0.4464.169-3.723
YOY1.5735.337-3.764
5Y1.0576.122-5.065
10Y1.0076.434-5.427
1.3.2. Quick Ratio

Measures if Biora Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 0.25 means the company can pay off $0.25 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biora Therapeutics Inc:

  • The MRQ is 0.255. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.356. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.356-0.102
TTM0.356YOY1.297-0.941
TTM0.3565Y0.854-0.498
5Y0.85410Y0.814+0.041
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2553.504-3.249
TTM0.3563.991-3.635
YOY1.2975.371-4.074
5Y0.8546.088-5.234
10Y0.8146.395-5.581

1.4. Solvency of Biora Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biora Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biora Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 4.25 means that Biora Therapeutics Inc assets are financed with 424.9% credit (debt) and the remaining percentage (100% - 424.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biora Therapeutics Inc:

  • The MRQ is 4.249. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 4.089. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.249TTM4.089+0.160
TTM4.089YOY2.671+1.417
TTM4.0895Y2.286+1.802
5Y2.28610Y2.177+0.109
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.2490.339+3.910
TTM4.0890.337+3.752
YOY2.6710.271+2.400
5Y2.2860.368+1.918
10Y2.1770.388+1.789
1.4.2. Debt to Equity Ratio

Measures if Biora Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biora Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.392-0.392
TTM-0.403-0.403
YOY-0.335-0.335
5Y-0.427-0.427
10Y-0.461-0.461

2. Market Valuation of Biora Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biora Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Biora Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -0.64 means the investor is paying $-0.64 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biora Therapeutics Inc:

  • The EOD is -0.352. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.638. Based on the earnings, the company is expensive. -2
  • The TTM is -0.905. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.352MRQ-0.638+0.286
MRQ-0.638TTM-0.905+0.267
TTM-0.905YOY-0.868-0.037
TTM-0.9055Y-0.697-0.207
5Y-0.69710Y-0.664-0.033
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.352-2.300+1.948
MRQ-0.638-2.656+2.018
TTM-0.905-2.718+1.813
YOY-0.868-4.145+3.277
5Y-0.697-6.258+5.561
10Y-0.664-6.315+5.651
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biora Therapeutics Inc:

  • The EOD is -0.393. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.712. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.575. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.393MRQ-0.712+0.319
MRQ-0.712TTM-1.575+0.863
TTM-1.575YOY-0.725-0.850
TTM-1.5755Y-1.005-0.571
5Y-1.00510Y-0.957-0.048
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.393-2.974+2.581
MRQ-0.712-3.306+2.594
TTM-1.575-3.508+1.933
YOY-0.725-5.613+4.888
5Y-1.005-8.378+7.373
10Y-0.957-8.873+7.916
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biora Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.39 means the investor is paying $-0.39 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biora Therapeutics Inc:

  • The EOD is -0.214. Based on the equity, the company is expensive. -2
  • The MRQ is -0.388. Based on the equity, the company is expensive. -2
  • The TTM is -0.664. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.214MRQ-0.388+0.174
MRQ-0.388TTM-0.664+0.276
TTM-0.664YOY-0.357-0.307
TTM-0.6645Y-1.693+1.029
5Y-1.69310Y-1.613-0.081
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.2141.914-2.128
MRQ-0.3882.116-2.504
TTM-0.6642.097-2.761
YOY-0.3572.881-3.238
5Y-1.6933.550-5.243
10Y-1.6133.936-5.549
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biora Therapeutics Inc.

3.1. Institutions holding Biora Therapeutics Inc

Institutions are holding 66.067% of the shares of Biora Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Athyrium Capital Management LP40.169221.43831092976200
2023-12-31Vanguard Group Inc1.8668050793522918382.2175
2023-12-31Geode Capital Management, LLC0.341909303839674.4538
2023-12-31BlackRock Inc0.239106505100
2023-12-31Susquehanna International Group, LLP0.1869050849508490
2023-09-30Schonfeld Strategic Advisors LLC0.15110.0007411003000.7353
2023-12-31Bridgeway Capital Management, LLC0.1370.00113728000
2023-12-31State Street Corporation0.121603307300
2023-12-31Millennium Management LLC0.09470257711242193.0412
2023-12-31LPL Financial Corp0.0761020716-818-3.7986
2023-12-31Virtu Financial LLC0.07260.002119763197630
2023-12-31Northern Trust Corp0.0572015561425537.6349
2023-12-31CIBC Global Asset Management Inc0.05550.00011511000
2023-12-31Engineers Gate Manager LP0.05540.000615085150850
2023-12-31Wells Fargo & Co0.030815680.0982
2023-12-31Tower Research Capital LLC0.02660.0001722970243426.3415
2023-12-31UBS Group AG0.02260614661460
2023-12-31Barclays PLC0.02130579700
2023-12-31Morgan Stanley - Brokerage Accounts0.017704820146743.7519
2023-12-31TD Waterhouse Canada Inc0.00410112011200
Total 43.747421.44311903362+350770+2.9%

3.2. Funds holding Biora Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.2273037203400
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.44830.000213590100
2024-02-29Fidelity Extended Market Index0.21750.000265931-319-0.4815
2023-12-31Bridgeway Ultra-Small Company Market0.1230.02713728000
2024-03-31NT Ext Equity Mkt Idx Fd - L0.10460.00063171220924193.9562
2024-02-29Fidelity Nasdaq Composite Index0.05690.00021724800
2023-12-31CIBC US Broad Market Index0.04980.00151511000
2024-02-29Fidelity Series Total Market Index0.046501408100
2023-12-31Northern Trust Extended Eq Market Idx0.03560.000310788425565.1309
2023-09-30BlackRock Extended Mkt Composite0.03450.00021045300
2024-03-31BlackRock Extended Equity Market K0.03010.0001912330.0329
2024-02-29Fidelity Total Market Index0.02780843000
2024-02-29Schwab Total Stock Market Index0.02770.0001839800
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0140.0001424900
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.01130.0001341360.1761
2024-03-31BlackRock U.S. Equity Market F0.008802673260.9822
2024-02-29Spartan Total Market Index Pool E0.00820247400
2024-03-31State St US Extended Mkt Indx NL Cl C0.00720.0001217600
2023-12-31SSgA U.S. Extended Market Index Class I0.00720.0001217600
2024-02-29Spartan Extended Market Index Pool E0.00570.0001174131922.4332
Total 2.4920.031755391+25214+3.3%

3.3. Insider Transactions

Insiders are holding 0.888% of the shares of Biora Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-07-05Surbhi SarnaSELL12381.25

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Biora Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.025-100%-0.0830%-0.1420%-0.1350%
Book Value Per Share---2.836-3.093+9%-2.802-1%-2.540-10%-2.419-15%
Current Ratio--0.3030.446-32%1.573-81%1.057-71%1.007-70%
Debt To Asset Ratio--4.2494.089+4%2.671+59%2.286+86%2.177+95%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%0.006-100%
Eps---0.431-0.853+98%-0.318-26%-1.042+142%-1.024+138%
Free Cash Flow Per Share---0.386-0.352-9%-0.371-4%-0.773+100%-0.766+98%
Free Cash Flow To Equity Per Share--0.003-0.124+4231%-0.257+8694%-0.039+1401%-0.073+2551%
Gross Profit Margin--1.0001.0000%1.0000%1.173-15%1.195-16%
Intrinsic Value_10Y_max--35.481--------
Intrinsic Value_10Y_min--28.610--------
Intrinsic Value_1Y_max---1.447--------
Intrinsic Value_1Y_min---1.425--------
Intrinsic Value_3Y_max---0.536--------
Intrinsic Value_3Y_min---0.589--------
Intrinsic Value_5Y_max--4.972--------
Intrinsic Value_5Y_min--4.286--------
Market Cap21711176.000-81%39344800.00075738740.000-48%36545954.000+8%87608350.800-55%83436524.571-53%
Net Profit Margin----2225.8750%-3053.6650%-1087.7160%-1035.9440%
Operating Margin----1867.3750%-2266.5560%-845.5690%-805.3260%
Operating Ratio---1887.750-100%2289.924-100%863.643-100%822.587-100%
Pb Ratio-0.214+45%-0.388-0.664+71%-0.357-8%-1.693+336%-1.613+316%
Pe Ratio-0.352+45%-0.638-0.905+42%-0.868+36%-0.697+9%-0.664+4%
Price Per Share0.607-81%1.1002.118-48%1.022+8%2.449-55%2.333-53%
Price To Free Cash Flow Ratio-0.393+45%-0.712-1.575+121%-0.725+2%-1.005+41%-0.957+34%
Quick Ratio--0.2550.356-29%1.297-80%0.854-70%0.814-69%
Return On Assets---0.494-0.866+75%-0.245-50%-0.423-14%-0.403-18%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.025-100%-0.0830%-0.1420%-0.1290%
Usd Book Value---101421000.000-110627250.000+9%-100208500.000-1%-90841400.000-10%-86515619.048-15%
Usd Book Value Change Per Share---0.025-100%-0.0830%-0.1420%-0.1350%
Usd Book Value Per Share---2.836-3.093+9%-2.802-1%-2.540-10%-2.419-15%
Usd Dividend Per Share----0%-0%-0%0.006-100%
Usd Eps---0.431-0.853+98%-0.318-26%-1.042+142%-1.024+138%
Usd Free Cash Flow---13811000.000-12574750.000-9%-13256500.000-4%-27639700.000+100%-27403857.143+98%
Usd Free Cash Flow Per Share---0.386-0.352-9%-0.371-4%-0.773+100%-0.766+98%
Usd Free Cash Flow To Equity Per Share--0.003-0.124+4231%-0.257+8694%-0.039+1401%-0.073+2551%
Usd Market Cap21711176.000-81%39344800.00075738740.000-48%36545954.000+8%87608350.800-55%83436524.571-53%
Usd Price Per Share0.607-81%1.1002.118-48%1.022+8%2.449-55%2.333-53%
Usd Profit---15413000.000-30521750.000+98%-14089500.000-9%-37090250.000+141%-36467809.524+137%
Usd Revenue---500.000-100%50000.000-100%9835300.000-100%11629190.476-100%
Usd Total Gains Per Share---0.025-100%-0.0830%-0.1420%-0.1290%
 EOD+1 -6MRQTTM+11 -17YOY+7 -175Y+10 -1510Y+10 -17

4.2. Fundamental Score

Let's check the fundamental score of Biora Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.352
Price to Book Ratio (EOD)Between0-1-0.214
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.255
Current Ratio (MRQ)Greater than10.303
Debt to Asset Ratio (MRQ)Less than14.249
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.494
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Biora Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.985
Ma 20Greater thanMa 500.692
Ma 50Greater thanMa 1000.949
Ma 100Greater thanMa 2001.045
OpenGreater thanClose0.611
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets31,215
Total Liabilities132,636
Total Stockholder Equity-101,421
 As reported
Total Liabilities 132,636
Total Stockholder Equity+ -101,421
Total Assets = 31,215

Assets

Total Assets31,215
Total Current Assets19,071
Long-term Assets12,144
Total Current Assets
Cash And Cash Equivalents 15,211
Net Receivables 830
Other Current Assets 3,030
Total Current Assets  (as reported)19,071
Total Current Assets  (calculated)19,071
+/-0
Long-term Assets
Property Plant Equipment 2,770
Goodwill 6,072
Long-term Assets Other 302
Long-term Assets  (as reported)12,144
Long-term Assets  (calculated)9,144
+/- 3,000

Liabilities & Shareholders' Equity

Total Current Liabilities62,972
Long-term Liabilities69,664
Total Stockholder Equity-101,421
Total Current Liabilities
Short-term Debt 2,872
Accounts payable 2,843
Other Current Liabilities 56,715
Total Current Liabilities  (as reported)62,972
Total Current Liabilities  (calculated)62,430
+/- 542
Long-term Liabilities
Long-term Liabilities  (as reported)69,664
Long-term Liabilities  (calculated)0
+/- 69,664
Total Stockholder Equity
Common Stock25
Retained Earnings -950,958
Other Stockholders Equity 849,512
Total Stockholder Equity (as reported)-101,421
Total Stockholder Equity (calculated)-101,421
+/-0
Other
Cash and Short Term Investments 15,211
Common Stock Shares Outstanding 24,811
Current Deferred Revenue542
Liabilities and Stockholders Equity 31,215
Net Debt 32,215
Net Working Capital -43,901
Short Long Term Debt Total 47,426



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-31
> Total Assets 
0
0
0
101,727
110,951
186,416
119,617
154,440
128,577
119,946
97,681
108,839
86,738
77,101
62,614
53,525
53,243
49,673
34,703
31,215
31,215
31,21531,21534,70349,67353,24353,52562,61477,10186,738108,83997,681119,946128,577154,440119,617186,416110,951101,727000
   > Total Current Assets 
0
0
0
74,648
83,768
159,967
93,037
126,338
101,171
114,326
92,970
98,429
75,020
60,145
46,360
38,116
37,168
33,885
19,247
19,071
19,071
19,07119,07119,24733,88537,16838,11646,36060,14575,02098,42992,970114,326101,171126,33893,037159,96783,76874,648000
       Cash And Cash Equivalents 
0
0
0
33,042
11,646
113,613
60,013
92,076
65,276
65,991
54,136
88,397
67,234
48,506
37,060
30,486
30,463
26,452
12,569
15,211
15,211
15,21115,21112,56926,45230,46330,48637,06048,50667,23488,39754,13665,99165,27692,07660,013113,61311,64633,042000
       Net Receivables 
0
0
0
22,823
53,935
29,978
13,425
12,682
13,206
5,047
1,917
653
0
817
828
828
828
819
818
830
830
83083081881982882882881706531,9175,04713,20612,68213,42529,97853,93522,823000
       Other Current Assets 
0
0
0
1,370
1,893
130
1,028
9,361
683
539
1,302
7,232
1,147
1,060
798
4,199
309
193
172
3,030
3,030
3,0303,0301721933094,1997981,0601,1477,2321,3025396839,3611,0281301,8931,370000
   > Long-term Assets 
0
0
0
27,079
27,183
26,449
26,580
28,102
27,406
5,620
4,711
10,410
11,718
16,956
16,254
15,409
16,075
15,788
15,456
12,144
12,144
12,14412,14415,45615,78816,07515,40916,25416,95611,71810,4104,7115,62027,40628,10226,58026,44927,18327,079000
       Property Plant Equipment 
0
0
0
15,891
16,226
15,725
16,088
17,842
17,377
5,474
4,564
4,012
5,320
4,657
3,955
3,136
3,744
3,238
3,070
2,770
2,770
2,7702,7703,0703,2383,7443,1363,9554,6575,3204,0124,5645,47417,37717,84216,08815,72516,22615,891000
       Goodwill 
0
0
0
6,219
6,219
6,219
6,219
6,219
6,219
6,219
6,219
6,072
6,072
6,072
6,072
6,072
6,072
6,072
6,072
6,072
6,072
6,0726,0726,0726,0726,0726,0726,0726,0726,0726,0726,2196,2196,2196,2196,2196,2196,2196,219000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
6,000
6,000
6,000
6,000
6,000
6,000
3,000
0
03,0006,0006,0006,0006,0006,0006,0000000000000000
       Intangible Assets 
0
0
0
4,771
4,539
4,307
4,075
3,843
3,611
3,384
3,384
0
0
0
0
0
0
0
0
0
0
00000000003,3843,3843,6113,8434,0754,3074,5394,771000
       Other Assets 
0
0
0
0
0
0
0
0
0
146
147
326
326
227
6,227
0
6,259
478
0
0
0
0004786,25906,227227326326147146000000000
> Total Liabilities 
0
0
0
185,601
195,745
203,576
180,037
261,434
254,084
259,555
274,647
193,815
179,923
173,207
160,057
155,812
158,241
170,554
153,489
132,636
132,636
132,636132,636153,489170,554158,241155,812160,057173,207179,923193,815274,647259,555254,084261,434180,037203,576195,745185,601000
   > Total Current Liabilities 
0
0
0
100,337
74,247
94,852
87,346
72,670
80,062
85,637
103,273
61,609
46,725
40,584
27,391
23,305
25,083
37,668
69,544
62,972
62,972
62,97262,97269,54437,66825,08323,30527,39140,58446,72561,609103,27385,63780,06272,67087,34694,85274,247100,337000
       Short-term Debt 
0
0
0
968
874
763
667
583
500
202
110
12
1,430
1,468
1,234
893
890
810
962
1,976
2,872
2,8721,9769628108908931,2341,4681,43012110202500583667763874968000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
275
74
75
12
0
0
0
0
0
0
0
1,976
0
01,976000000012757427500000000
       Accounts payable 
0
0
0
15,754
16,963
15,679
15,666
17,410
15,625
14,560
7,989
8,709
5,380
4,315
2,356
3,606
3,422
5,042
3,905
2,843
2,843
2,8432,8433,9055,0423,4223,6062,3564,3155,3808,7097,98914,56015,62517,41015,66615,67916,96315,754000
       Other Current Liabilities 
0
0
0
6,044
4,708
4,153
70,469
54,299
63,726
70,432
94,913
52,587
39,721
34,712
23,742
18,759
20,727
31,774
64,635
58,153
56,715
56,71558,15364,63531,77420,72718,75923,74234,71239,72152,58794,91370,43263,72654,29970,4694,1534,7086,044000
   > Long-term Liabilities 
0
0
0
85,264
121,498
108,724
92,691
188,764
174,022
173,918
171,374
132,206
133,198
132,623
132,666
132,507
133,158
132,886
83,945
69,664
69,664
69,66469,66483,945132,886133,158132,507132,666132,623133,198132,206171,374173,918174,022188,76492,691108,724121,49885,264000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
127,086
0
0
128,185
128,568
0
0
0
000128,568128,18500127,0860000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
15,147
14,110
5,814
5,363
4,857
5,221
0
4,973
3,191
0
0
0
0003,1914,97305,2214,8575,3635,81414,11015,147000000000
> Total Stockholder Equity
0
0
0
-83,874
-84,794
-17,160
-60,420
-106,994
-125,507
-139,609
-176,966
-84,976
-93,185
-96,106
-97,443
-102,287
-104,998
-120,881
-118,786
-101,421
-101,421
-101,421-101,421-118,786-120,881-104,998-102,287-97,443-96,106-93,185-84,976-176,966-139,609-125,507-106,994-60,420-17,160-84,794-83,874000
   Common Stock
0
0
0
38
39
50
50
59
63
82
83
146
148
150
153
8
11
11
21
25
25
252521111181531501481468382635950503938000
   Retained Earnings Total Equity000-862,091-844,28400-808,0070000000000000
   Accumulated Other Comprehensive Income 000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
730,833
0
0
758,353
760,277
0
0
0
000760,277758,35300730,8330000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
0
0
264,566
280,797
401,471
405,276
434,221
447,968
512,378
518,764
703,564
709,161
711,751
715,525
724,548
739,275
741,199
816,738
849,512
849,512
849,512849,512816,738741,199739,275724,548715,525711,751709,161703,564518,764512,378447,968434,221405,276401,471280,797264,566000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4
Cost of Revenue-555
Gross Profit-551-551
 
Operating Income (+$)
Gross Profit-551
Operating Expense-66,592
Operating Income-67,143-67,143
 
Operating Expense (+$)
Research Development29,838
Selling General Administrative38,106
Selling And Marketing Expenses0
Operating Expense66,59267,944
 
Net Interest Income (+$)
Interest Income0
Interest Expense-9,815
Other Finance Cost-845
Net Interest Income-10,660
 
Pretax Income (+$)
Operating Income-67,143
Net Interest Income-10,660
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-124,424-9,862
EBIT - interestExpense = -76,958
-124,205
-114,300
Interest Expense9,815
Earnings Before Interest and Taxes (EBIT)-67,143-114,609
Earnings Before Interest and Taxes (EBITDA)-66,588
 
After tax Income (+$)
Income Before Tax-124,424
Tax Provision-264
Net Income From Continuing Ops-122,171-124,688
Net Income-124,115
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses67,147
Total Other Income/Expenses Net-57,28110,660
 

Technical Analysis of Biora Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biora Therapeutics Inc. The general trend of Biora Therapeutics Inc is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biora Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biora Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.67 < 0.756 < 0.7677.

The bearish price targets are: 0.585.

Tweet this
Biora Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biora Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biora Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biora Therapeutics Inc. The current macd is -0.10901235.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biora Therapeutics Inc price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biora Therapeutics Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biora Therapeutics Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Biora Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiora Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biora Therapeutics Inc. The current adx is 30.67.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biora Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Biora Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biora Therapeutics Inc. The current sar is 0.77147234.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biora Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biora Therapeutics Inc. The current rsi is 32.98. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Biora Therapeutics Inc Daily Relative Strength Index (RSI) ChartBiora Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biora Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biora Therapeutics Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Biora Therapeutics Inc Daily Stochastic Oscillator ChartBiora Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biora Therapeutics Inc. The current cci is -83.23518065.

Biora Therapeutics Inc Daily Commodity Channel Index (CCI) ChartBiora Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biora Therapeutics Inc. The current cmo is -39.296696.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biora Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartBiora Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biora Therapeutics Inc. The current willr is -85.80645161.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Biora Therapeutics Inc Daily Williams %R ChartBiora Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biora Therapeutics Inc.

Biora Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biora Therapeutics Inc. The current atr is 0.07107124.

Biora Therapeutics Inc Daily Average True Range (ATR) ChartBiora Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biora Therapeutics Inc. The current obv is 112,787,721.

Biora Therapeutics Inc Daily On-Balance Volume (OBV) ChartBiora Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biora Therapeutics Inc. The current mfi is 21.01.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Biora Therapeutics Inc Daily Money Flow Index (MFI) ChartBiora Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biora Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-04-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Biora Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biora Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5032.985
Ma 20Greater thanMa 500.692
Ma 50Greater thanMa 1000.949
Ma 100Greater thanMa 2001.045
OpenGreater thanClose0.611
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biora Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Biora Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biora Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biora Therapeutics Inc

I send you an email if I find something interesting about Biora Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biora Therapeutics Inc.

Receive notifications about Biora Therapeutics Inc in your mailbox!